Centre for Research in Evidence-Based Practice, Faculty of Health Sciences and Medicine, Bond University, Queensland, Australia2School of Health and Rehabilitation Sciences, University of Queensland, Brisbane, Australia.
Centre for Research in Evidence-Based Practice, Faculty of Health Sciences and Medicine, Bond University, Queensland, Australia.
JAMA Intern Med. 2015 Feb;175(2):274-86. doi: 10.1001/jamainternmed.2014.6016.
Unrealistic patient expectations of the benefits and harms of interventions can influence decision making and may be contributing to increasing intervention uptake and health care costs.
To systematically review all studies that have quantitatively assessed patients' expectations of the benefits and/or harms of any treatment, test, or screening test.
A comprehensive search strategy was used in 4 databases (MEDLINE, Embase, Cumulative Index to Nursing and Allied Health Literature, PsycINFO) up to June 2013, with no language or study type restriction. We also ran cited reference searches of included studies and contacted experts and study authors. Two researchers independently evaluated methodological quality and extracted participants' estimates of benefit and harms and authors' contemporaneous estimates.
Of the 15,343 records screened, 36 articles (from 35 studies) involving a total of 27,323 patients were eligible. Fourteen studies focused on a screen, 15 on treatment, 3 a test, and 3 on treatment and screening. More studies assessed only benefit expectations (22 [63%]) than benefit and harm expectations (10 [29%]) or only harm (3 [8%]). Fifty-four outcomes (across 32 studies) assessed benefit expectations: of the 34 outcomes with overestimation data available, the majority of participants overestimated benefit for 22 (65%) of them. For 17 benefit expectation outcomes, we could not calculate the proportion of participants who overestimated or underestimated, although for 15 (88%) of these, study authors concluded that participants overestimated benefits. Expectations of harm were assessed by 27 outcomes (across 13 studies): underestimation data were available for 15 outcomes and the majority of participants underestimated harm for 10 (67%) of these. A correct estimation by at least 50% of participants only occurred for 2 outcomes about benefit expectations and 2 outcomes about harm expectations.
The majority of participants overestimated intervention benefit and underestimated harm. Clinicians should discuss accurate and balanced information about intervention benefits and harms with patients, providing the opportunity to develop realistic expectations and make informed decisions.
患者对干预措施的益处和危害的不切实际的期望会影响决策,并且可能是导致干预措施接受度增加和医疗保健成本上升的原因之一。
系统地回顾所有定量评估患者对任何治疗、测试或筛查测试的益处和/或危害的期望的研究。
使用全面的搜索策略在 4 个数据库(MEDLINE、Embase、护理与健康相关文献累积索引、PsycINFO)中进行检索,截止到 2013 年 6 月,没有语言或研究类型的限制。我们还对纳入研究的参考文献进行了追溯检索,并联系了专家和研究作者。两名研究人员独立评估了方法学质量,并提取了参与者对益处和危害的估计值以及作者同期的估计值。
在筛选出的 15343 条记录中,有 36 篇文章(来自 35 项研究)涉及 27323 名患者符合纳入标准。其中 14 项研究侧重于筛查,15 项研究侧重于治疗,3 项研究侧重于测试,3 项研究侧重于治疗和筛查。评估益处期望的研究多于评估益处和危害期望的研究(22 [63%] vs 10 [29%])或仅评估危害期望的研究(3 [8%])。有 54 个结局(来自 32 项研究)评估了益处期望:在 34 个有高估数据的结局中,大多数参与者高估了 22 个(65%)的益处。对于 17 个益处期望结局,我们无法计算出高估或低估参与者的比例,但对于其中 15 个(88%),研究作者得出结论,参与者高估了益处。通过 27 个结局(来自 13 项研究)评估了危害期望:有 15 个结局有低估数据,大多数参与者低估了其中 10 个(67%)的危害。至少有 50%的参与者做出正确估计的只有 2 个关于益处期望的结局和 2 个关于危害期望的结局。
大多数参与者高估了干预措施的益处,低估了危害。临床医生应与患者讨论干预措施的益处和危害的准确和平衡信息,为他们提供机会,使他们形成现实的期望并做出明智的决策。